Critical evaluation of the human relevance of the mode of action for rodent liver tumor formation by activators of the constitutive androstane receptor (CAR)
被引:26
作者:
Yamada, Tomoya
论文数: 0引用数: 0
h-index: 0
机构:
Sumitomo Chem Co Ltd, Environm Hlth Sci Lab, Osaka, JapanSumitomo Chem Co Ltd, Environm Hlth Sci Lab, Osaka, Japan
Yamada, Tomoya
[1
]
Cohen, Samuel M.
论文数: 0引用数: 0
h-index: 0
机构:
Univ Nebraska Med Ctr, Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE USASumitomo Chem Co Ltd, Environm Hlth Sci Lab, Osaka, Japan
Cohen, Samuel M.
[2
]
Lake, Brian G.
论文数: 0引用数: 0
h-index: 0
机构:
Univ Surrey, Fac Hlth & Med Sci, Guildford, Surrey, EnglandSumitomo Chem Co Ltd, Environm Hlth Sci Lab, Osaka, Japan
Lake, Brian G.
[3
]
机构:
[1] Sumitomo Chem Co Ltd, Environm Hlth Sci Lab, Osaka, Japan
[2] Univ Nebraska Med Ctr, Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE USA
[3] Univ Surrey, Fac Hlth & Med Sci, Guildford, Surrey, England
Many nongenotoxic chemicals have been shown to produce liver tumors in mice and/or rats by a mode of action (MOA) involving activation of the constitutive androstane receptor (CAR). Studies with phenobarbital (PB) and other compounds have identified the key events for this MOA: CAR activation; increased hepatocellular proliferation; altered foci formation; and ultimately the development of adenomas/carcinomas. In terms of human relevance, the pivotal species difference is that CAR activators are mitogenic agents in mouse and rat hepatocytes, but they do not stimulate increased hepatocellular proliferation in humans. This conclusion is supported by substantial in vitro studies with cultured rodent and human hepatocytes and also by in vivo studies with chimeric mice with human hepatocytes. Examination of the literature reveals many similarities in the hepatic effects and species differences between activators of rodent CAR and the peroxisome proliferator-activated receptor alpha (PPAR alpha), with PPAR alpha activators also not being mitogenic agents in human hepatocytes. Overall, a critical analysis of the available data demonstrates that the established MOA for rodent liver tumor formation by PB and other CAR activators is qualitatively not plausible for humans. This conclusion is supported by data from several human epidemiology studies.